Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Syngens Logo
Syngens Growth Score
75
CB Rank
411138
Heat Score
34
Programming biology for biomanufacturing using generative AI
Founded
obfuscation
PrivateNon-equity Assistance Trondheim, Sor-Trondelag, Norway1-10 syngens.ai
Alternative Protein
Biofuel
Biotechnology
CleanTech
Generative AI
Manufacturing
Waste Management
Overview

Syngens
Growth Score
75
Heat Score
34

Growth Score75
-10 pts
in past quarter
Heat Score 34
-16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Syngens

CB Rank
411138
Programming biology for biomanufacturing using generative AI
Founded
obfuscation
PrivateNon-equity Assistance Trondheim, Sor-Trondelag, Norway1-10 syngens.ai
Alternative Protein
Biofuel
Biotechnology
CleanTech
Generative AI
Manufacturing
Waste Management

Funding Rounds

Non-equity Assistance
OBF
in
obfuscation

Details

Legal Name Syngens AS
Operating Status Active
Company Type For Profit
About the Company
A DNA design company accelerating the transition to a sustainable future. We make biology predictable by combining AI with 'omics data.
Contact Email hello@syngens.ai
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AI-powered DNA Design Platform
A platform that designs and optimizes DNA sequences using AI to enable precise and predictable genetic engineering across multiple organisms.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance
obfuscation
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
1
obfuscation
MassChallengeNon-equity Assistance

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
MassChallenge Logo
MassChallenge
Yes
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
—
MassChallenge Logo
MassChallenge
Yes
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
—
MassChallenge Logo
MassChallenge
Yes
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
—
MassChallenge Logo
MassChallenge
Yes
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
—
MassChallenge Logo
MassChallenge
Yes
Non Equity Assistance - Syngens Logo
Non Equity Assistance - Syngens
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News
Technology
View Tech Report

Monthly Web Visits

16
-90%
 in past month

IT Spend

$55.7KThis year, Syngens is projected to spend $55.7K on IT, according to Aberdeen.

Active Website Tech Count

2Syngens is actively using 2 technologies for its website, according to BuiltWith. These include Common Crawl and  CommonCrawl Top 5m.
Sub-Organizations
Frequently Asked Questions

Where is Syngens's headquarters? Syngens is located in Trondheim, Sor-Trondelag, Norway.Who invested in Syngens? Syngens is funded by MassChallenge.When was the last funding round for Syngens? Syngens closed its last funding round on
obfuscation
from a Non-equity Assistance round.Who are Syngens's competitors? Alternatives and possible competitors to Syngens may include Generate Biomedicines, Cradle, and  Ginkgo Bioworks.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8c8a01a 1)
|